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In this issue of the Journal of Thoracic Oncology, Berthiller et al.1 present the results ofa pooled analysis of three hospital based case-control studies performed to estimate the
risk of lung cancer from cannabis smoking in men. Data regarding smoking, demograph-
ics, and occupational exposures were gathered through a questionnaire. In two of the three
studies, each case (men with primary incident lung cancer) was matched to one or two
controls based on age and place of residence and matched on age, gender, and place of
residence in the third study. The authors use an unconditional logistic regression model to
obtain the study specific and pooled odds ratio estimates. All analyses were performed on
the complete set of cases and controls as well as on data with the recoded missing
variables. The analyses techniques used in this article include unconditional logistic
regression models, pooling of data without stratifying by study, and testing for between
study heterogeneity, and the (biased) approaches for recoding the missing data. These
approaches are somewhat inappropriate, however, in this editorial we will focus only on
the case-control study design highlighting the benefits, limitations, and appropriate
analysis methods.
Recent research has shown that a substantial majority of highly cited case-control
studies are subsequently contradicted or found to be substantially over-ambitious when
more rigorous investigations are conducted.2 While a prospective double blind random-
ized controlled trial remains the ‘Gold standard’ of study design, such trials may not be
logistically and scientifically possible for studying diseases that have infrequent events
that require large populations to be tracked for lengthy periods to observe disease
development. Case-control studies are a perfect alternative to randomized controlled trial
in such cases, as they use data from patients who already have a disease or the condition
of interest and look back to see if there are characteristics of these patients that differ from
those who don’t have the disease or the condition of interest. This design essentially
compares two groups of people with regard to the risk factor(s) of interest: those with the
disease or condition under study (cases) and a very similar group of people who do not
have the disease or condition (controls).3
An important aspect of case-control study design is the concept of matching controls
to cases based on certain features. Matching on well established confounders helps to
address confounder-related distributional imbalance problems in cases and controls at the
design stage, however, matching on a factor that is a consequence of the exposure is
inappropriate. Matching can be done in two different ways. Group or frequency matching
ensures that there are the same number of controls as cases within each level of
confounder. While this helps reduce bias, it does not necessarily eliminate it. A finer level
of matching is achieved by matching each case with one or more controls. Berthiller et al.1
do not provide details on the type of matching, but given the factors used for matching,
specifically, age and place of residence, it is likely that a group/frequency matching was
used. Next is the decision on the ideal matching, i.e., 1:1, 1:2, 1:3 and so on. This typically
depends on the number of variables to be matched, availability of controls and cost of
Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
Disclosure: The authors declare no conflicts of interest.
Address for correspondence: Sumithra J. Mandrekar, PhD, Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55901. E-mail:
mandrekar.sumithra@mayo.edu
Copyright © 2008 by the International Association for the Study of Lung Cancer
ISSN: 1556-0864/08/0312-1371
Journal of Thoracic Oncology • Volume 3, Number 12, December 2008 1371
matching. In many instances, this decision is based on an
investigator’s prior knowledge and experience about the dis-
ease. The gain in statistical efficiency diminishes beyond 4 or
5 controls for each case, specifically the efficiency for 1, 2, 3,
4, and 5 controls per case is approximately 0.5, 0.67, 0.75,
0.8, and 0.83.4 It is common practice, however, to match two
controls per case, as done in two of three studies in the article
by Berthiller et al.1
A conditional logistic regression model involving a
stratified analysis on the matching factors is used for the
analysis of matched case-control study design.5 Simply
speaking, unlike an unconditional (i.e., ordinary) logistic
regression model used for an unmatched case-control study,
the conditional approach keeps track of which case was
matched with which control(s) at the design stage in the
logistic regression model, thus providing greater statistical
efficiency. This concept is analogous to using a paired t test
(versus a 2 sample t test) when the measurements (i.e., data)
are paired and the outcome of interest is continuous. An
unconditional logistic regression model used in a matched
case-control design setting, as done by Berthiller et al.,1 does
not use the matching information, resulting in possibly incor-
rect model specification and biased estimates.
In summary, case-control studies, when designed and
analyzed correctly, are a valuable investigative tool that can
provide rapid results at low cost for diseases with low incidences
that take a long time to manifest. Caution should be exercised in
interpreting results from these studies due to their retrospective
and non-randomized nature. Moreover, ascertainment of dis-
ease, selection of controls, and measurement of exposure need
careful consideration in a case-control study design.
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